Table 2.
Metabolite | Platform | ALT | APAP-Protein Adducts |
---|---|---|---|
2-Oxoarginine a | LCMS POS, 0.72 min, m/z 174.09 | 0.6192, p = 2.40 × 10−2 | 0.4318 |
Ascorbic acid a | LCMS POS, 0.72 min, m/z 177.04 | 0.4361 | 0.8446, p = 2.81 × 10−4 |
Ascorbic acid a | LCMS NEG, 0.72 min, m/z 175.02 | 0.3889 | 0.8159, p = 6.72 × 10−4 |
Alanine | NMR, 1.47, 3.78 ppm | 0.2600 | 0.6792, p = 1.073 × 10−2 |
Choline | NMR, 3.19, 3.51, 4.06 ppm | 0.1789 | 0.5993, p = 3.04 × 10−2 |
Citrulline a | LCMS POS, 0.67 min, m/z 176.10 | −0.3810 | −0.6676, p = 1.27 × 10−2 |
Cresol a | LCMS NEG, 3.77 min, m/z 107.05 | −0.5642, p = 4.46 × 10−2 | −0.4348 |
Fructose | NMR, 3.55–4.11 ppm | 0.3900 | 0.8170, p = 6.51 × 10−4 |
Glucose | NMR, 3.23–3.89, 4.64 ppm | 0.2778 | 0.6367, p = 1.93 × 10−2 |
Hippurate a | LCMS NEG, 3.32 min, m/z 178.05 | 0.4858 | 0.8561, p = 1.88 × 10−4 |
Hippurate | NMR, 3.96, 7.54, 7.63, 7.82 ppm | 0.4116 | 0.8350, p = 3.82 × 10−4 |
Hydroxybutyrylcarnitine a | LCMS POS, 1.05 min, m/z 248.15 | −0.5674, p = 4.46 × 10−2 | −0.4900 |
Indoxyl a | LCMS POS, 3.30 min, m/z 134.06 | 0.7062, p = 6.98 × 10−3 | 0.8230, p = 5.49 × 10 −4 |
Lactate | NMR, 1.32, 4.11 ppm | - | 0.7906, p = 1.29 × 10−3 |
Proline a | LCMS POS, 0.83 min, m/z 116.07 | −0.5733, p = 4.05 × 10−2 | −0.5376 |
Propylene glycol | NMR, 1.13, 3.44, 3.54, 3.88 ppm | 0.4025 | 0.8263, p = 4.99 × 10−4 |
Pyruvate | NMR, 2.36 ppm | 0.3680 | 0.7134, p = 6.18 × 10−3 |
Taurocholic acid isomer b | LCMS NEG, 4.83 min, m/z 514.28 | 0.4259 | 0.6891, p = 9.18 × 10−3 |
Trimethylamine N-oxide | NMR, 3.25 ppm | 0.5807, p = 3.74 × 10−2 | 0.3733 |
Uracil a | LCMS POS, 0.78 min, m/z 113.03 | - | 0.6349, p = 1.97 × 10−2 |
Uric acid a | LCMS NEG, 0.83 min, m/z 167.02 | - | 0.5636, p = 4.49 × 10−2 |
a Compounds identified based upon an authentic standard from an in-house database; b Compounds identified from the Human Metabolome Database.